Clinical study of Shenzhujing pill in the treatment of Consumptive Disease(Qi and Yin deficiency )

Clinical study of Shenzhujing pill in the treatment of Consumptive Disease(Qi and Yin deficiency)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300074859

Enrollment

Unknown

Registered

2023-08-18

Start date

2023-08-20

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consumptive Disease

Interventions

treatment group:Shen Zhu Jing Pian

control group:placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for the disease; (2) Conforming to the standards of Qi and Yin deficiency syndrome; (3) 35 = age = 70 years old; (4) Sign an informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Being in an incurable state of illness that may lead to fatigue; Mental illness, depression; Mental disorders; Dementia; Anorexia or bulimia; Abuse of alcohol or other substances; Extreme obesity. (2) Patients with severe illnesses such as heart, liver, kidney, and hematopoietic system; (3) Pregnant or recently prepared women, as well as lactating women; (4) People who are allergic to multiple Drug allergy or known to be allergic to the components of this drug; (5) Participants in other clinical trials during the trial observation period.

Design outcomes

Primary

Measure	Time frame
Fatigue scale;TCM syndrome score;	—

Secondary

Measure	Time frame
VAS scale; SF-36;	—

Countries

China

Contacts

Public ContactLiu Zhanbiao

Tianjin University of Traditional Chinese Medicine

634256747@qq.com+86 188 1267 7868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026